Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sanofi Genzyme, the specialty care global business unit... Read more
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sanofi Genzyme, the specialty care global business unit... Read more
Are you an adult 18 – 65 years of age... Read more
SANOFI GENZYME – We are proud to announce the first... Read more
As a culmination of Gaucher Awareness Month, on October 30,... Read more
Researchers have linked Gaucher disease to a slightly increased risk... Read more
It’s important to monitor Gaucher disease with regular assessments. For... Read more
Summary: The National Gaucher Foundation today mourns the passing of... Read more
Are you an adult 18 – 65 years of age... Read more
In the blink of an eye, life completely changed for... Read more
Sanofi Genzyme established the Chart Your Own Course program four... Read more
Living a Better Today